Petrobras still assessing plans for Braskem stake but no plans to sell – report

Must read

Gilead Sciences on track to snap its six-day winning streak

Shares of Gilead Sciences (NASDAQ:GILD) were on track to end their six-day gaining streak on Thursday, noting their first decline since November 29....

AbbVie shares set for seventh straight session of gains

AbbVie (NYSE:ABBV) shares were on track for their seventh consecutive session of gains on Thursday, as the stock rose nearly 1% to 147.54...

Meta Platforms on track to snap six-day red streak

Meta Platforms' (NASDAQ:META) shares are on track to break a 6-day losing streak after losing about 4.4% over the last 6 trading sessions....

Kenvue gains amid hearing on purported Tylenol linkage to autism in children (update)

Scott Olson/Getty Images News Update 1:35pm: Updates shares, adds court hearing ended. Kenvue Inc. (NYSE:KVUE), the consumer health company...
Bolsonaro Considers Privatization of Oil State Company Petrobras

Wagner Meier/Getty Images News

Braskem (NYSE:BAK) closed +7.3% in Thursday’s trading after Brazilian newspaper Valor Economico reported Petrobras (NYSE:PBR) is not planning to sell its 36% in the petrochemical company.

Petrobras CEO (PBR) Jean Paul Prates reportedly said during a meeting with analysts that the company has no plans to sell the stake.

Following the report, Petrobras (PBR) said it is studying alternatives in the petrochemicals sector as part of its strategic planning, but it did directly address the report.

Petrobras (PBR) is one of Braskem’s (BAK) main shareholders alongside conglomerate Novonor, which owns a controlling stake but wants to sell it to repay creditors after entering bankruptcy protection.

More on Petrobras:

More articles

Latest article

Gilead Sciences on track to snap its six-day winning streak

Shares of Gilead Sciences (NASDAQ:GILD) were on track to end their six-day gaining streak on Thursday, noting their first decline since November 29....

AbbVie shares set for seventh straight session of gains

AbbVie (NYSE:ABBV) shares were on track for their seventh consecutive session of gains on Thursday, as the stock rose nearly 1% to 147.54...

Meta Platforms on track to snap six-day red streak

Meta Platforms' (NASDAQ:META) shares are on track to break a 6-day losing streak after losing about 4.4% over the last 6 trading sessions....

Kenvue gains amid hearing on purported Tylenol linkage to autism in children (update)

Scott Olson/Getty Images News Update 1:35pm: Updates shares, adds court hearing ended. Kenvue Inc. (NYSE:KVUE), the consumer health company...

FedEx shares on track to record its seventh straight session of gains

Sundry Photography/iStock Editorial via Getty Images Global delivery firm FedEx (NYSE:FDX) shares are on track to record its seventh...